Autoinjectors Market worth $300.46 billion by 2031
The report "Autoinjectors Market by Type (Devices, Finished Formulation), Usage (Disposable, Reusable), Actuation Mechanism (Mechanical, Electronic), Therapy (Rheumatoid Arthritis, Obesity, Diabetes), ROA (SC, IM), Volume (< 3ml, > 3ml) - Global Forecast to 2031", is projected to reach USD 300.46 billion by 2031 from USD 127.30 billion in 2026, at a CAGR of 18.7% during the forecast period.
Browse 550 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Autoinjectors Market by Type (Devices, Finished Formulation), Usage (Disposable, Reusable), Actuation Mechanism (Mechanical, Electronic), Therapy (Rheumatoid Arthritis, Obesity, Diabetes), ROA (SC, IM), Volume (< 3ml, > 3ml) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html
The autoinjectors market is expected to grow significantly during the forecast period, driven by the rising prevalence of chronic and autoimmune diseases, increasing regulatory approvals for autoinjectors, and the growing adoption of self-administered medicines. The increased use of autoinjectors in hospitals, clinics, and home care settings is boosting demand for high-quality, safe, and dependable devices to ensure accurate drug delivery and patient safety. Additionally, the rising need for continuous medication administration for chronic illnesses further fuels market growth. Technological advancements, such as needle-free autoinjectors, smart Bluetooth-enabled autoinjectors, and built-in sensor devices, are improving efficiency and safety, supporting wider adoption. Emerging economies present significant opportunities due to expanding healthcare infrastructure and increased investments in modern medical technologies.
“By usage, the disposable autoinjectors segment is expected to register the highest CAGR during the forecast period.”
Based on usage, the market is divided into disposable autoinjectors and reusable autoinjectors. In 2025, disposable autoinjectors was the fastest-growing segment, driven by their ease of use, increasing demand for self-administration, and lower risk of cross-contamination or infection, making them highly favored in modern healthcare environments. Innovations in reusable autoinjectors, such as digital interfaces, ergonomic designs, and greater awareness of sustainability, are boosting the adoption of reusable autoinjectors.
“By actuation mechanism, the mechanical (spring-based) autoinjectors segment held the largest share of the market in 2025.”
Based on actuation mechanism, the market is segmented into mechanical (spring-based) autoinjectors and electronic autoinjectors. Mechanical autoinjectors account for the largest share of the autoinjectors market, driven by their simpler design, reliability, and cost-effectiveness. The growth is further supported by patients preferring the unique click sound that provides physical confirmation that the injection has begun or ended. However, advancements in electronic autoinjectors, such as integration of digital connectivity, real-time feedback, mobile tracking, and adherence monitoring, are supporting the widespread adoption of electronic autoinjectors.
“By drug type, biologics are projected to register the highest growth rate in the autoinjectors market.”
Based on drug type, the market is segmented into biologics, biosimilars, and small molecules. Biologics is the dominant segment of the autoinjectors market, driven by increasing use in treating chronic diseases such as diabetes, arthritis, and oncology. The growing pipeline of monoclonal antibodies and other injectable biologics has also further supported the growth of the biologics segment in the autoinjectors market. Since high-viscosity biologics require motorized delivery, autoinjectors remain a preferred choice, which further fuels the demand for autoinjectors.
“The market in North America is expected to hold the largest share of the autoinjectors market throughout the forecast period.”
North America leads the global autoinjectors market mainly because of its high healthcare spending, strong reimbursement policies, and the increasing shift toward home-based treatment. The region also benefits from the concentration of major pharmaceutical and medical device hubs. Meanwhile, the Asia Pacific region is expected to see the highest CAGR in the autoinjectors market during the forecast period. This growth is fueled by improvements in healthcare infrastructure, substantial investments in local manufacturing, and a growing population. Consequently, demand for autoinjectors is climbing in this area.
Some of the leading companies in the device-only autoinjectors market include Becton, Dickinson and Company (US), SHL Medical (Switzerland), and Ypsomed (Switzerland). Key players in the finished formulation autoinjectors market include Novo Nordisk (Denmark), AbbVie Inc. (US), and Eli Lilly and Company (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Autoinjectors Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
